Systems and devices for assessment and treatment of a myocardial ischemic event

• US 20070228721A1
• Filed: 02/14/2007
• Published: 10/04/2007
• Est. Priority Date: 02/15/2006
• Status: Abandoned Application

• Current Assignee: Michael Laposata
• Original Assignee: Michael Laposata
• Inventors: Laposata, Michael
• Application Number:
  US11/706,926
• Publication Number:
  US 20070228721A1
• Time in Patent Office: Days
• US Class Current: 283/115
• CPC Class Codes: A61B 50/3001 for sharps
• CPC Class Codes: A61F 17/00 First-aid kits

Abstract

The invention relates to a medical kit for use by a patient to assess and treat an ischemic event. The medical kit of the invention provides instructions for the patient to assess symptoms associated with a myocardial ischemic event, assign a category of likelihood of an ischemic event, and treat the ischemic event based on the assigned category. The medical kit further comprises a set of medications for treating the myocardial ischemic event according to the treatment instructions for the assigned risk category.

Claims

1. A medical kit for use by a patient for assessing and treating a myocardial ischemic event, the kit comprising:

(a) a written protocol comprising

(1) instructions for assessing symptoms associated with a myocardial ischemic event to assign a category of risk for the ischemic event; and

(2) instructions for treating the ischemic event based on the assigned risk category; and

(b) a set of medications for treating the ischemic event according to the treatment instructions appropriate for the likelihood that the symptoms reflect a myocardial event.

2. The kit of claim 1, wherein the ischemic event is a heart attack.

3. The kit of claim 1, wherein the symptoms are selected from the group consisting of:

chest pain as experienced in a previous heart attack, a pressing sensation on the chest, chest pain, left arm pain, left arm numbness, chest tightness, pounding heart, sweating, sense of impending doom, jaw pain, shortness of breath, neck pain, inappropriate sweating, nausea, an anxious feeling, and a frightened feeling.

4. The kit of claim 1, wherein the symptoms are selected from the group consisting of:

chest pain, chest tightness, sensation similar to a previous heart attack, and left arm pain or numbness.

5. The kit of claim 1, wherein the written protocol comprises:

instructions for a patient to determine whether he/she is experiencing symptoms associated with an ischemic event and to assign a category of likelihood that the symptoms reflect a myocardial event based upon the symptoms experienced; and

instructions for treatment based upon the likelihood of an ischemic event

6. The kit of claim 1, wherein the assessment instructions comprise instructions for the patient to assess the presence or absence of the symptoms associated with an ischemic event and assign a score based upon the presence or absence of the symptoms.

7. The kit of claim 6, wherein the assessment instructions comprise the following inquiries:

a first inquiry, whether the patient is experiencing chest pain similar to a previous heart attack;

a second inquiry, whether the patient is experiencing a pressing sensation on the chest;

a third inquiry, whether the patient is experiencing;

left arm pain, left arm numbness, chest tightness, pounding heart, sweating, a sense of impending doom, jaw pain, shortness of breath, neck pain, inappropriate sweating, or nausea; and

a fourth inquiry, whether the patient is experiencing an anxious or frightened feeling.

8. The kit of claim 1, wherein the protocol is set forth in a flow chart diagram.

9. The kit of claim 8, wherein the flow chart diagram comprises a series of nodes, wherein each node comprises a symptom associated with an ischemic event and progress through the flow chart depends on the presence or absence of the symptoms resulting in an assigned risk category.

10. The kit of claim 5, wherein the treatment instructions comprise instructions for administration of one or more medications based upon the assigned risk category.

11. The kit of claim 6, wherein the treatment instructions comprise instructions for administration of one or more medications based on the assessed likelihood of an ischemic event.

12. The kit of claim 9, wherein the treatment instructions comprise instructions for administration of one or more medications based upon the assigned risk category.

13. The kit of claim 1, wherein the set of medications comprises an aspirin, a β

-blocker, and an anticoagulant.

14. The kit of claim 13, wherein the set of medications further comprises, an antiplatelet agent, an ACE inhibitor, or a nitroglycerin compound.

15. The kit of claim 6, wherein the treatment instructions comprise:

a first category with instructions to immediately contact a healthcare provider;

a second category with instructions to treat with an aspirin tablet and immediately contact a healthcare provider; and

a third category with instructions to treat with aspirin, a beta-blocker, and an anticoagulant and immediately contact a healthcare provider.

16. The kit of claim 9, wherein the treatment instructions comprise:

(a) a first category with instructions to immediately contact a healthcare provider;

(b) a second category with instructions to treat with an aspirin tablet and immediately contact a healthcare provider;

(c) a third category with instructions to treat with an aspirin, a beta-blocker, and an anticoagulant and immediately contact a healthcare provider.

17. The kit of claim 1, further comprising a point of care test.

18. The kit of claim 17, wherein the point of care test is selected from the group consisting of myoglobin, creatine kinase-MB (CKMB), and troponin.

19. A method of using the kit of claim 1, the method comprising:

(a) determining whether a patient is at risk for having an ischemic event;

(b) prescribing the kit of claim 1 to the patient if the patient is a risk for having an ischemic event; and

(c) instructing the patient on how to use the kit of claim 1.

21. The kit of claim 1, further comprising:

(a) a carrying case wherein each medication is stored and labeled; and

(b) individual wrapping and clear instructions for oral medications.

20. A medical kit for use by a patient for assessing and treating a myocardial ischemic event, the kit comprising:

(a) a protocol comprising (1) instructions for assessing symptoms associated with an ischemic event to assign a category of risk for the ischemic event; and

(2) instructions for treating the ischemic event based on the assigned risk category;

wherein the protocol is in an electronic form; and

(b) a set of medications for treating the ischemic event according to the treatment instructions for the assigned risk category.

22. A medical kit for use by a patient for assessing and treating a heart attack, the kit comprising:

(a) a written protocol comprising (1) instructions for the patient to assess the presence or absence of symptoms associated with a myocardial ischemia and assign a category of likelihood based upon the presence or absence of the symptoms; and

(2) instructions for treating the heart attack based on the assigned risk category, wherein the treatment instructions comprise;

(a) a first category with instructions to immediately contact a healthcare provider;

(b) a second category with instructions to treat with one or more medications and immediately contact a healthcare provider; and

(c) a third category with instructions to treat with one or more medications and immediately contact a healthcare provider.

23. The kit of claim 22, wherein the instructions to treat with a set of medications comprise:

instructions to treat with an aspirin tablet and immediately contact a healthcare provider;

instructions to treat with an aspirin and a beta-blocker and immediately contact a healthcare provider; and

instructions to treat with an aspirin, a beta-blocker, and heparin or other anticoagulant and immediately contact a healthcare provider

24. The kit may contain an opening mechanism that provides varying access to the medications contained within the kit, dependent upon the patient'"'"'s answers to the assessment of likelihood of an event. The kit may therefore open to reveal only one, or some, or all of the medications for the patient'"'"'s use, with this unique opening mechanism.